ÂÜÀòÂÒÂ×

Mr. Zygmont brings over 17 years of experience in finance to the company with a wide range of industry applications. Since 2016, Mr. Zygmont has been building Jivanas, a social enterprise that owns and operates a factory in Nepal helping create jobs for people at risk for human trafficking. Jivanas has operations in Nepal, Hong Kong, and the USA. During 2013, Mr. Zygmont started oOxesis Biotechnology LLC, a biologics lab that worked on developing therapies for unmet needs. From June 2012 to January 2016, Mr. Zygmont was the Interim CFO and Senior Director of Finance at La Jolla Pharmaceutical Company (La Jolla). During Mr. Zygmont’s tenure at La Jolla, he brought the company to NASDAQ listing. Prior to La Jolla, Mr. Zygmont served as Managing Director at Z3 Capital, LLC from March 2009 to June 2012. Z3 Capital, LLC, a privately held investment firm, focused on investment acquisition and venture funding for multiple startup companies in real estate, medical device and biotechnology. Mr. Zygmont also served as Vice President at Symmetry Advisors, Inc., a private equity leveraged buyout firm. While at Symmetry, he managed finance for its public sector fund, was a key player on a $600 million buyout of a portfolio company, and subsequently led the restructuring of its manufacturing division. Mr. Zygmont earned his M.S. in Finance from Baruch College, Zicklin School of Business and his B.A. from Eastern University.